Adbry/Adtralza Global Market Report 2025

Global Adbry/Adtralza Market Report 2025

Adbry/Adtralza Global Market Report 2025 ) – By Indication (Atopic Dermatitis, Other Dermatological Conditions,), By Distribution Channel (Hospital and Clinics, Retail and Specialty Pharmacies), By End User (Adult Patients, Geriatric Patients) – Market Size, Trends, And Global Forecast 2025-2034

Name: Adbry/Adtralza Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Adbry/Adtralza Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Adbry/Adtralza Global Market Report 2025

Proud Members Of

Adbry/Adtralza Market Definition

Adbry (also known as adtralza) is a monoclonal antibody medication used to treat moderate to severe eczema (atopic dermatitis) in adults and children aged 6 years and older. It works by inhibiting interleukin-13 (IL-13), a protein involved in the inflammatory process of eczema. By targeting IL-13, Adbry/Adtralza helps reduce skin inflammation, itching, and rashes.

The main indication for adbry/adtralza are atopic dermatitis, other dermatological conditions. Atopic dermatitis (AD) is a chronic skin condition characterized by itchy, inflamed skin that can lead to significant discomfort and impact daily life. These are distributed through various distribution channels such as hospital and clinics, retail and specialty pharmacies and are used by various end users such as adult patients, geriatric patients.

Adbry/Adtralza Market Segmentation

The adbry/adtralzamarket covered in this report is segmented –

1) By Indication: Atopic Dermatitis, Other Dermatological Conditions,

2) By Distribution Channel: Hospital and Clinics, Retail and Specialty Pharmacies

3) By End User: Adult Patients, Geriatric Patients

Adbry/Adtralza Market Size and growth rate 2025 to 2029: Graph

Adbry/Adtralza Market Size 2025 And Growth Rate

The adbry/adtralza market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to FDA approval, increasing acceptance among dermatologists, regulatory developments, expansion into new markets, and growing demand for biologic treatments.

Adbry/Adtralza Market Growth Forecast

The adbry/adtralza market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increased prevalence of atopic dermatitis, growing awareness and diagnosis, innovative delivery systems, expansion into emerging markets, focus on personalized medicine. Major trends in the forecast period include increased adoption rates, focus on real-world evidence, regulatory approvals for new indications, shift towards Personalized medicine, competitive landscape dynamics.

Book your 30 minutes free consultation with our research experts

Adbry/Adtralza Market Driver: Rising Atopic Dermatitis Prevalence Fuels Growth of Adbry/Adtralza Market

The rising prevalence of atopic dermatitis is expected to propel the growth of the adbry/adtralza market going forward. Atopic dermatitis, commonly known as eczema, refers to a chronic inflammatory skin condition characterized by intense itching, redness, and irritation. The rising prevalence of atopic dermatitis is due to factors such as increased air pollution, urban living conditions, changes in childhood skin care practices, and genetic predispositions. Adbry/adtralza, a monoclonal antibody targeting the interleukin-13 (IL-13) pathway, helps atopic dermatitis by reducing inflammation and immune system overactivity, thereby alleviating symptoms such as itching, redness, and skin irritation in patients with moderate-to-severe forms of the condition. For instance, in December 2023, according to the National Library of Medicine (NLM), the US-based biomedical library, the global prevalence of atopic dermatitis is estimated at 2.6%, affecting approximately 204.05 million people worldwide, with about 101.27 million adults and 102.78 million children diagnosed with the condition. Therefore, the rising prevalence of atopic dermatitis is driving the adbry/adtralza market.

Adbry/Adtralza Market Driver: The Rising Healthcare Expenditure Is Significantly Driving The Adbry/Adtralza Market Growth

The rising healthcare expenditure is expected to propel the growth of adbry/adtralza market going forward. Healthcare expenditure refers to the total amount spent on health services and related activities within a certain period, typically measured annually. Healthcare expenditure refers to the total amount of money spent on healthcare services and products within a specific period. Healthcare expenditure plays a crucial role in supporting the availability and accessibility of innovative treatments such as Adbry (also known as adtralza), as increased spending on healthcare systems enables the coverage and distribution of advanced biologics for the management of conditions such as moderate-to-severe atopic dermatitis, improving patient outcomes while also facilitating broader access to these essential therapies. For instance, in May 2024, according to a report published by Office For National Statistics, a UK-based government agency, total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of 0.9% in 2022. Additionally, total long-term health and social care expenditure increased by 2.8% in real terms in 2022. Therefore, the rising healthcare expenditure is driving the growth of adbry/adtralza market.

Global Adbry/Adtralza Market Major Players

Major companies operating in the adbry/adtralza market include LEO Pharma Inc.

Global Adbry/Adtralza Market Trend: Advancements In Biologic Treatments For Atopic Dermatitis With Leo Pharma's Expansion Of Adbry (Tralokinumab-ldrm) Approval

The key trend in the adbry/adtralza market is focusing on developing approved drugs such as biologic treatment specifically designed to inhibit interleukin-13 (IL-13) to gain improved therapeutic outcomes for patients with atopic dermatitis. Biologic treatment refers to a type of therapy that uses biologically derived substances, such as monoclonal antibodies, proteins, or vaccines, to target specific components of the immune system or cellular processes involved in diseases, offering a more targeted and often more effective approach for conditions like autoimmune disorders, cancer, and chronic inflammatory diseases. For instance, in December 2023, Leo Pharma, a Denmark-based pharmaceutical company, U.S. Food and Drug Administration (FDA) has expanded the approval of Adbry (tralokinumab-ldrm) to include pediatric patients aged 12 to 17 years with moderate-to-severe atopic dermatitis (AD). This marks Adbry as the first and only biologic specifically designed to inhibit interleukin-13 (IL-13), a key cytokine involved in the inflammatory processes of atopic dermatitis.

Regional Outlook For The Global Adbry/Adtralza Market

North America was the largest region in the adbry/adtralza market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adbry/adtralza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the adbry/adtralza market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Adbry/Adtralza Market?

The adbry/adtralza market consists of sales of adbry (Tralokinumab-ldrm), adtralza (Tralokinumab), delgocitinib, TMB-001, and fucidin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Adbry/Adtralza Industry?

The adbry/adtralza market research report is one of a series of new reports from The Business Research Company that provides adbry/adtralza market statistics, including adbry/adtralza industry global market size, regional shares, competitors with a adbry/adtralza market share, detailed adbry/adtralza market segments, market trends, and opportunities, and any further data you may need to thrive in the adbry/adtralza industry. This adbry/adtralza market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Adbry/Adtralza Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	CAGR of from 2025 to 2034
Revenue Forecast In 2034	2024
Growth Rate	2019-2024
Base Year For Estimation	2025 - 2029 - 2034
Actual Estimates/Historical Data	Revenue in USD Billion and CAGR from 2025 to 2034
Forecast Period	1) By Indication: Atopic Dermatitis, Other Dermatological Conditions, 2) By Distribution Channel: Hospital and Clinics, Retail and Specialty Pharmacies 3) By End User: Adult Patients, Geriatric Patients
Market Representation	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Segments Covered	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Regional Scope	LEO Pharma Inc.
Country Scope	Request for Sample
Key Companies Profiled	Explore Purchase Options
Customization Scope
Pricing And Purchase Options

1. Executive Summary

2. Adbry/Adtralza Market Characteristics

3. Adbry/Adtralza Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Adbry/Adtralza Market Trends And Strategies

5. Adbry/Adtralza Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

6. Global Adbry/Adtralza Growth Analysis And Strategic Analysis Framework

6.1. Global Adbry/Adtralza PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Adbry/Adtralza Market Growth Rate Analysis

6.4. Global Adbry/Adtralza Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

6.5. Global Adbry/Adtralza Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

6.6. Global Adbry/Adtralza Total Addressable Market (TAM)

7. Global Adbry/Adtralza Market Pricing Analysis & Forecasts

8. Adbry/Adtralza Market Segmentation

8.1. Global Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Atopic Dermatitis

Other Dermatological Conditions

8.2. Global Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital and Clinics

Retail and Specialty Pharmacies

8.3. Global Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adult Patients

Geriatric Patients

9. Global Adbry/Adtralza Market Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Adbry/Adtralza Market Regional And Country Analysis

10.1. Global Adbry/Adtralza Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. Global Adbry/Adtralza Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Asia-Pacific Adbry/Adtralza Market

11.1. Asia-Pacific Adbry/Adtralza Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Asia-Pacific Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Asia-Pacific Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. China Adbry/Adtralza Market

12.1. China Adbry/Adtralza Market Overview

12.2. China Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.3. China Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

12.4. China Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

13. India Adbry/Adtralza Market

13.1. India Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. India Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. India Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. Japan Adbry/Adtralza Market

14.1. Japan Adbry/Adtralza Market Overview

14.2. Japan Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. Japan Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. Japan Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Australia Adbry/Adtralza Market

15.1. Australia Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.2. Australia Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Australia Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. South Korea Adbry/Adtralza Market

16.1. South Korea Adbry/Adtralza Market Overview

16.2. South Korea Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. South Korea Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.4. South Korea Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Western Europe Adbry/Adtralza Market

17.1. Western Europe Adbry/Adtralza Market Overview

17.2. Western Europe Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Western Europe Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.4. Western Europe Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. UK Adbry/Adtralza Market

18.1. UK Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. UK Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. UK Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Germany Adbry/Adtralza Market

19.1. Germany Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Germany Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Germany Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. France Adbry/Adtralza Market

20.1. France Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. France Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. France Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adbry/Adtralza Market

21.1. Eastern Europe Adbry/Adtralza Market Overview

21.2. Eastern Europe Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. North America Adbry/Adtralza Market

22.1. North America Adbry/Adtralza Market Overview

22.2. North America Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. North America Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.4. North America Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. USA Adbry/Adtralza Market

23.1. USA Adbry/Adtralza Market Overview

23.2. USA Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. USA Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. USA Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. Canada Adbry/Adtralza Market

24.1. Canada Adbry/Adtralza Market Overview

24.2. Canada Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. Canada Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. Canada Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. South America Adbry/Adtralza Market

25.1. South America Adbry/Adtralza Market Overview

25.2. South America Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. South America Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. South America Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. Middle East Adbry/Adtralza Market

26.1. Middle East Adbry/Adtralza Market Overview

26.2. Middle East Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. Middle East Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. Middle East Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Africa Adbry/Adtralza Market

27.1. Africa Adbry/Adtralza Market Overview

27.2. Africa Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Africa Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.4. Africa Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Adbry/Adtralza Market Competitive Landscape And Company Profiles

28.1. Adbry/Adtralza Market Competitive Landscape

28.2. Adbry/Adtralza Market Company Profiles

28.2.1. LEO Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Adbry/Adtralza Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Adbry/Adtralza Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Adbry/Adtralza Market

32. Recent Developments In The Adbry/Adtralza Market

33. Adbry/Adtralza Market High Potential Countries, Segments and Strategies

33.1 Adbry/Adtralza Market In 2029 - Countries Offering Most New Opportunities

33.2 Adbry/Adtralza Market In 2029 - Segments Offering Most New Opportunities

33.3 Adbry/Adtralza Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Adbry/Adtralza Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Adbry/Adtralza Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Asia-Pacific, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Asia-Pacific, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: China, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: China, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: India, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: India, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Japan, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: Japan, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Australia, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Australia, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: South Korea, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: South Korea, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: South Korea, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Western Europe, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Western Europe, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Western Europe, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: UK, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: UK, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: UK, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Germany, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Germany, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Germany, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: France, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: France, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: France, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Eastern Europe, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Eastern Europe, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Eastern Europe, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: North America, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: North America, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: North America, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: USA, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: USA, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: USA, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Canada, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Canada, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Canada, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: South America, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: South America, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: South America, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Middle East, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Middle East, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Middle East, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Africa, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Africa, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Africa, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: LEO Pharma Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Adbry/Adtralza Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Adbry/Adtralza Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Asia-Pacific, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Asia-Pacific, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: China, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: China, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: India, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: India, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Japan, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: Japan, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Australia, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Australia, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: South Korea, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: South Korea, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: South Korea, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Western Europe, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Western Europe, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Western Europe, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: UK, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: UK, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: UK, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Germany, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Germany, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Germany, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: France, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: France, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: France, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Eastern Europe, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Eastern Europe, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Eastern Europe, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: North America, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: North America, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: North America, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: USA, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: USA, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: USA, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Canada, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Canada, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Canada, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: South America, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: South America, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: South America, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Middle East, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Middle East, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Middle East, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Africa, Adbry/Adtralza Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Africa, Adbry/Adtralza Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Africa, Adbry/Adtralza Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: LEO Pharma Inc. Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the anti-asthmatic and copd drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the dry eye medication market research report 2022 with industry size, share, segments and market growth

Dermatitis Global Market Report 2025 – By Drug Class (Corticosteroids, Emollients/Moisturizers, Antihistamines, Calcineurin Inhibitors, Antibiotics, Immunomodulators, Interleukin Inhibitors ), By Distribution Channel (Hospital, Retail Pharmacies, Drug Stores, Online Or Mail Pharmacies), By Application (Cancer, Blood Disorders, Chronic Diseases, Infectious Diseases) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Atopic Dermatitis Global Market Report 2025 – By Drug Class (Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes), By Mode of Administration (Topical, Injectable, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Arthritis Monoclonal Antibodies Global Market Report 2025 – By Drug (Remicade, Humira, Enbrel, Rituxan, Orencia, Actemra, Simponi, Cimzia, Remsima), By Application (Rheumatoid Arthritis, Osteoarthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Other Applications), By End-Use (Hospitals, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Biosimilar Monoclonal Antibodies Global Market Report 2025 – By Type (Synthetic Chemicals, Biopharmaceuticals, Other Types), By Compound (Infliximab, Rituximab, Abciximab, Trastuzumab, Adalimumab, Bevacizumab), By Application (Chronic & Autoimmune Diseases, Oncology, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Breast Cancer Monoclonal Antibodies Global Market Report 2025 – By Product (Naked Mabs, Conjugated Mabs), By Treatment (Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone Therapy), By End-User (Hospitals, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Conjugated Monoclonal Antibodies Global Market Report 2025 – By Drugs (Adcetris, Kadcyla), By Technology (Cleavable Linker, Non-cleavable Linker), By Application (Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Monoclonal Antibodies (MAs) Global Market Report 2025 – By Source (Murine, Chimeric, Humanized, Human), By Application (Anti-Cancer, Immunological, Anti-Infective Monoclonal Antibodies (MAs), Neuropharmacological, Cardiovascular And Cerebrovascular, Other Applications), By End Users (Hospitals, Private Clinics, Research Institute) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Monoclonal Antibodies Global Market Report 2025 – By Monoclonal Antibody Therapies (Avastin, Herceptin, Keytruda, Opdivo, Darzalex, Perjeta, Others), By Application (Breast Cancer, Blood Cancer, Lung Cancer, Brain Tumor, Colorectal Cancer, Cervical Cancer, Gastric Cancer, Others), By End-User (Hospitals, Research Laboratories, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Adbry/Adtralza market?

How will the Adbry/Adtralza market drivers and restraints affect the market dynamics? What forces will shape the Adbry/Adtralza industry going forward?

The Adbry/Adtralza market major growth driver - Rising Atopic Dermatitis Prevalence Fuels Growth of Adbry/Adtralza Market. For further insights on the Adbry/Adtralza market, request a sample here

What is the forecast market size or the forecast market value of the Adbry/Adtralza market?

The Adbry/Adtralza market size has grown strongly in recent years. The adbry/adtralza market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to FDA approval, increasing acceptance among dermatologists, regulatory developments, expansion into new markets, and growing demand for biologic treatments. The adbry/adtralza market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increased prevalence of atopic dermatitis, growing awareness and diagnosis, innovative delivery systems, expansion into emerging markets, focus on personalized medicine. Major trends in the forecast period include increased adoption rates, focus on real-world evidence, regulatory approvals for new indications, shift towards Personalized medicine, competitive landscape dynamics. For further insights on the Adbry/Adtralza market, request a sample here

How is the Adbry/Adtralza market segmented?

The adbry/adtralzamarket covered in this report is segmented –
1) By Indication: Atopic Dermatitis; Other Dermatological Conditions;
2) By Distribution Channel: Hospital and Clinics; Retail and Specialty Pharmacies
3) By End User: Adult Patients; Geriatric Patients For further insights on the Adbry/Adtralza market, request a sample here

Which region has the largest share of the Adbry/Adtralza market? What are the other regions covered in the report?

Who are the major players in the Adbry/Adtralza market?

Major companies operating in the adbry/adtralza market include LEO Pharma Inc. . For further insights on the Adbry/Adtralza market, request a sample here.

What are the key trends in the Adbry/Adtralza market?

Major trends in the Adbry/Adtralza market include Advancements In Biologic Treatments For Atopic Dermatitis With Leo Pharma's Expansion Of Adbry (Tralokinumab-ldrm) Approval. For further insights on the Adbry/Adtralza market, request a sample here.

What are the major opportunities in the Adbry/Adtralza market? What are the strategies for the Adbry/Adtralza market?

For detailed insights on the major opportunities and strategies in the Adbry/Adtralza market, request a sample here.

How does the Adbry/Adtralza market relate to the overall economy and other similar markets?

For detailed insights on Adbry/Adtralza's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Adbry/Adtralza industry?

For detailed insights on the mergers and acquisitions in the Adbry/Adtralza industry, request a sample here.

What are the key dynamics influencing the Adbry/Adtralza market growth? SWOT analysis of the Adbry/Adtralza market.

For detailed insights on the key dynamics influencing the Adbry/Adtralza market growth and SWOT analysis of the Adbry/Adtralza industry, request a sample here.